Durata Therapeutics (Nasdaq: DRTX) announced that its Dutch subsidiary, Durata Therapeutics International B.V., has entered into a license and supply ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE